Global Therapeutic Vaccine Market (2020 to 2025) - Growth, Trends, and Forecasts -

DUBLIN--()--The "Therapeutic Vaccine Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to's offering.

Global Therapeutic Vaccine market is expected to witness a CAGR of 12.63%, during the forecast period. Certain factors that are driving the market growth include favorable government funding for vaccine development, rising prevalence of diseases, and an increase in R&D expenditure of the companies.

Increased awareness regarding the potential value of vaccination in the developed, developing, and under-developed regions of the world. Major governmental and humanitarian organizations have taken up an active interest in curbing the diseases prevented by vaccines and vaccinating the maximum number of infants and adults as possible, which led to the adoption of new production and supply strategies and the formation of the donor market, that accounts for the biggest market for vaccines, in terms of dosage, globally.

Companies Mentioned

  • Agenus Inc.
  • Argos Therapeutic Inc.
  • Celldex Therapeutic Inc.
  • Cytos Biotechnology AG
  • Dendreon Corp
  • GlaxoSmithKline
  • Merck & Co.
  • Novartis
  • Pfizer
  • Vaccinogen Inc.

Key Market Trends

Autoimmune Disease Vaccines is Expected to Hold Significant Market Share

Autoimmune diseases are those, which occur when the body's immune system attacks and destroys healthy tissues of the body by mistake. An autoimmune disorder can lead to the growth of a tumor, damage healthy tissues, and cause changes in the function of a specific organ. Autoimmune diseases can affect blood vessels, connective tissues, endocrine glands, joints, muscles, red blood cells, skin, etc. Autoimmune diseases are among the top ten leading causes for death among women in all age groups, spanning to those up to 65 years. A substantial minority of the population suffers from these diseases, which are attenuating, chronic, and fatal. The development of vaccines for different types of autoimmune diseases is underway.

North America Dominates the Market and Expected to do Same in the Forecast Period

The United States is the largest market in North America. Canadian and Mexican markets have high growth potentials, and the US market is focused on the invention and development of new vaccines. The demand for better and more efficient vaccines is expected to increase, which may reduce the shortfall of vaccines, during disease outbreaks. For example, the demand for the measles vaccines has increased drastically, due to the worst measles outbreak in North America over the past 15 years.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Favorable Government Funding For Vaccine Development

4.2.2 Rising Prevalence of Diseases

4.2.3 Increase in R&D Expenditure by the Companies

4.3 Market Restraints

4.3.1 Huge Capital Expenditures

4.3.2 Stringent Regulatory Framework

4.4 Porter's Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 Products

5.1.1 Autoimmune Disease Vaccines

5.1.2 Neurological Disease Vaccines

5.1.3 Cancer Vaccines

5.1.4 Infectious Disease Vaccines

5.1.5 Other Products

5.2 Technology

5.2.1 Allogeneic Vaccine

5.2.2 Autologous Vaccine

5.3 Geography

5.3.1 North America United States Canada Mexico

5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.3.4 Middle-East & Africa GCC South Africa Rest of Middle-East & Africa

5.3.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles


For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900